PeptidesForAlzheimers.ca

Why this name

Amyloid beta is itself a peptide, which makes this phrasing central rather than tangential to Alzheimer's science. The .ca extension anchors it to Canada specifically, where neurology research institutes, provincial health resources, and clinical trial recruitment all operate under national regulatory and linguistic expectations. For a Canadian audience, the country code reads as jurisdiction and legitimacy at once.

This fits a Toronto or Montreal research group, a Canadian trial recruitment portal, a patient advocacy chapter, or a clinic offering peptide-adjacent cognitive care within Canadian guidelines. Families searching for options want to know that what they find applies where they live. A .com raises questions about where the trial is and whether the treatment is available; the .ca answers both before the page loads.

Well suited to

• Canadian clinical trial recruitment page
• Neurology research group project site
• Provincial patient and caregiver resource hub
• Memory clinic service page
• Canadian advocacy chapter microsite

Ideal owner A Canadian neurology research institute, trial sponsor, or Alzheimer's advocacy organization.